Regulator of G protein signaling 2 is a functionally important negative regulator of angiotensin II-induced cardiac fibroblast responses

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 1, 2011, Pages

  Zhang, Peng ^a   Su, Jialin ^a   King, Michelle E ^a   Maldonado, Angel E ^a   Park, Cindy ^a   Mende, Ulrike ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Cell proliferation; Collagen; G proteins; Myofibroblasts; Phospholipase c

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PEPTIDES AND PROTEINS; PHOSPHOLIPASE C BETA; RGS10 PROTEIN; RGS11 PROTEIN; RGS17 PROTEIN; RGS18 PROTEIN; RGS2 PROTEIN; RGS20 PROTEIN; RGS3 PROTEIN; RGS5 PROTEIN; RGS7 PROTEIN; RGS8 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; CELL ACTIVATION; CELL ISOLATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; HEART MUSCLE CELL; HEART VENTRICLE; IN VITRO STUDY; MALE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; COLLAGEN; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HEART; HEART VENTRICLES; MALE; MYOCARDIUM; MYOFIBROBLASTS; PHOSPHOLIPASE C BETA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RGS PROTEINS; RNA INTERFERENCE; UP-REGULATION;

EID: 79959893606     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00026.2011     Document Type: Article

References (68)

1. Anger T, Zhang W, Mende U. Differential contribution of GTP aseactivation and effector antagonism to the inhibitory effect of RGS proteinson Gq-mediated signaling in vivo. J Biol Chem 279: 3906-3915, 2004.
2. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 293: H1883-H1891, 2007.
3. Baudino TA, Carver W, Giles W, Borg TK. Cardiac fibroblasts: friendor foe? Am J Physiol Heart Circ Physiol 291: H1015-H1026, 2006.
4. Bouzegrhane F, Thibault G. Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovasc Res 53: 304-312, 2002.
5. Brilla CG. Renin-angiotensin-aldosterone system and myocardial fibrosis. Cardiovasc Res 47: 1-3, 2000.
6. Brilla CG, Zhou G, Rupp H, Maisch B, Weber KT. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol 76: 8D-13D, 1995.
7. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45: 657-687, 2005.
8. Camelliti P, Borg TK, Kohl P. Structural and functional characterization of cardiac fibroblasts. Cardiovasc Res 65: 40-51, 2005.
9. Campbell SE, Janicki JS, Weber KT. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 27: 1545-1560,1995.
10. Campbell SE, Katwa LC. Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J MolCell Cardiol 29: 1947-1958, 1997.
11. Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA. Mechanisms contributing to angiotensin II regulation of body weight. AmJ Physiol Endocrinol Metab 274: E867-E876, 1998.
12. Crabos M, Roth M, Hahn AW, Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest 93: 2372-2378, 1994.
13. Dostal DE. The cardiac renin-angiotensin system: novel signaling mechanismsrelated to cardiac growth and function. Regul Pept 91: 1-11, 2000.
14. Doupnik CA, Xu T, Shinaman JM. Profile of RGS expression in singlerat atrial myocytes. Biochim Biophys Acta 1522: 97-107, 2001.
15. Frangogiannis NG, Michael LH, Entman ML. Myofibro blasts in reperfused myocardial infarcts express the embryonic form of smooth musclemyos in heavy chain (SMemb). Cardiovasc Res 48: 89-100, 2000.
16. Freed DH, Cunnington RH, Dangerfield AL, Sutton JS, Dixon IM.Emerging evidence for the role of cardiotrophin-1 in cardiac repair in theinfarcted heart. Cardiovasc Res 65: 782-792, 2005.
17. Fujita J, Mori M, Kawada H, Ieda Y, Tsuma M, Matsuzaki Y, Kawaguchi H, Yagi T, Yuasa S, Endo J, Hotta T, Ogawa S, Okano H, Yozu R, Ando K, Fukuda K. Administration of granulocyte colony stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibro blasts and contributes to cardiacrepair. Stem Cells 25: 2750-2759, 2007.
18. Gao X, He X, Luo B, Peng L, Lin J, Zuo Z. Angiotensin II increasescollagen I expression via transforming growth factor-beta1 and extra cellular signal-regulated kinase in cardiac fibroblasts. Eur J Pharmacol 606:115-120, 2009.
19. Grant SL, Lassegue B, Griendling KK, Ushio-Fukai M, Lyons PR, Alexander RW. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Mol Pharmacol 57:460-467, 2000.
20. Gross V, Tank J, Obst M, Plehm R, Blumer KJ, Diedrich A, Jordan J, Luft FC. Autonomic nervous system and blood pressure regulation in RGS2-deficient mice. Am J Physiol Regul Integr Comp Physiol 288:R1134-R1142, 2005.
21. Hao J, Michalek C, Zhang W, Zhu M, Xu X, Mende U. Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation. J Mol Cell Cardiol 41: 51-61,2006.
22. Hepler JR, Berman DM, Gilman AG, Kozasa T. RGS4 and GAIP are GTPase-activating proteins for Gqα and block activation of phospholipase Cβ by γ-thio-GTP-Gqα. Proc Natl Acad Sci USA 94: 428-432, 1997.
23. Heximer SP, Knutsen RH, Sun X, Kaltenbronn KM, Rhee MH, Peng N, Oliveira-dos-Santos A, Penninger JM, Muslin AJ, Steinberg TH, Wyss JM, Mecham RP, Blumer KJ. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 111: 445-452,2003.
24. Hinz B, Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb Haemost 90: 993-1002,2003.
25. Hollinger S, Hepler JR. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 54: 527-559, 2002.
26. Holtz J. Pathophysiology of heart failure and the renin-angiotensinsystem. Basic Res Cardiol, 88, Suppl 1: 183-201, 1993.
27. Huang XR, Chung AC, Yang F, Yue W, Deng C, Lau CP, Tse HF, Lan HY. Smad 3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 55: 1165-1171,2010.
28. Kardestuncer T, Wu H, Lim AL, Neer EJ. Cardiac myocytes expressm RNA for ten RGS proteins: changes in RGS mRNA expression in ventricular myocytes and cultured atria. FEBS Lett 438: 285-288, 1998.
29. Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE, Hsueh WA. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 101: 1130-1137, 2000.
30. Kehrl JH, Sinnarajah S. RGS2: a multifunctional regulator of G-protein signaling. Int J Biochem Cell Biol 34: 432-438, 2002.
31. Kimple AJ, Soundararajan M, Hutsell SQ, Roos AK, Urban DJ, Setola V, Temple BR, Roth BL, Knapp S, Willard FS, Siderovski DP. Structural determinants of G-protein α subunit selectivity by regulator of G-protein signaling 2 (RGS2). J Biol Chem 284: 19402-19411, 2009.
32. Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ. Angiotens in II stimulates the auto crine production of transforming growth factor-β1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27: 2347-2357, 1995.
33. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91: 1103-1113,2002.
34. Masur SK, Dewal HS, Dinh TT, Erenburg I, Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci USA 93: 4219-4223, 1996.
35. Mende U, Kagen A, Meister M, Neer EJ. Signal transduction in atria and ventricles of mice with transient cardiac expression of activated G protein αq. Circ Res 85: 1085-1091, 1999.
36. Mittmann C, Chung CH, Hoppner G, Michalek C, Nose M, Schuler C, Schuh A, Eschenhagen T, Weil J, Pieske B, Hirt S, Wieland T. Expression of ten RGS proteins in human myocardium: functional characterization of an up regulation of RGS4 in heart failure. Cardiovasc Res55: 778-786, 2002.
37. Motte S, McEntee K, Naeije R. Endothelin receptor antagonists. Pharmacol Ther 110: 386-414, 2006.
38. Nag AC. Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 28: 41-61, 1980.
39. Offermanns S. G-proteins as transducers in trans membrane signalling. Prog Biophys Mol Biol 83: 101-130, 2003.
40. Pedersen EB, Danielsen H, Jensen T, Madsen M, Sorensen SS, Thomsen OO. Angiotensin II, aldosterone and arginine vasopressin in plasma incongestive heart failure. Eur J Clin Invest 16: 56-60, 1986.
41. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardialre modeling. Pharmacol Ther 123: 255-278, 2009.
42. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol Cell Physiol 277: C1-C9, 1999.
43. Riddle EL, Schwartzman RA, Bond M, Insel PA. Multi-tasking RGS proteins in the heart: the next therapeutic target? Circ Res 96: 401-411,2005.
44. Ross EM, Wilkie TM. GTPase-activating proteins for hetero trimeric Gproteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69: 795-827, 2000.
45. Scheschonka A, Dessauer CW, Sinnarajah S, Chidiac P, Shi CS, Kehrl JH. RGS3 is a GTPase-activating protein for Giα and Gqα and a potentinhibitor of signaling by GTPase-deficient forms of Gqα and G11α. MolPharmacol 58: 719-728, 2000.
46. Sjogren B, Blazer LL, Neubig RR. Regulators of G protein signaling proteins as targets for drug discovery. Prog Mol Biol Transl Sci 91:81-119, 2010.
47. Song L, De Sarno P, Jope RS. Muscarinic receptor stimulation increasesregulators of G-protein signaling 2 mRNA levels through a protein kinaseC-dependent mechanism. J Biol Chem 274: 29689-29693, 1999.
48. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell. Circ Res 105: 1164-1176, 2009.
49. Sun Y, Weber KT. Animal models of cardiac fibrosis. Methods Mol Med117: 273-290, 2005.
50. Suo M, Hautala N, Foldes G, Szokodi I, Toth M, Leskinen H, Uusimaa P, Vuolteenaho O, Nemer M, Ruskoaho H. Posttranscriptional control of BNP gene expression in angiotens in II-induced hypertension. Hypertension39: 803-808, 2002.
51. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79: 215-262, 1999.
52. Takimoto E, Koitabashi N, Hsu S, Ketner EA, Zhang M, Nagayama T, Bedja D, Gabrielson KL, Blanton R, Siderovski DP, Mendelsohn ME, Kass DA. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and anti hypertrophic effects of PDE5 inhibition in mice. J Clin Invest 119: 408-420, 2009.
53. Tang M, Wang G, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y, Mendelsohn ME. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9: 1506-1512, 2003.
54. Tesmer JJ, Berman DM, Gilman AG, Sprang SR. Structure of RGS4bound to AlF4--activated Giα1: stabilization of the transition state for GTP hydrolysis. Cell 89: 251-261, 1997.
55. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363, 2002.
56. Tsang S, Woo AY, Zhu W, Xiao RP. Deregulation of RGS2 in cardiovascular diseases. Front Biosci (Schol Ed) 2: 547-557, 2010.
57. van Amerongen MJ, Bou-Gharios G, Popa E, van Ark J, Petersen AH, van Dam GM, van Luyn MJ, Harmsen MC. Bone marrow-derived myofibro blasts contribute functionally to scar formation after myocardial infarction. J Pathol 214: 377-386, 2008.
58. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88: 2849-2861, 1993.
59. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 345:1689-1697, 2001.
60. Weber KT, Sun Y, Katwa LC. Myofibro blasts and local angiotens in II inrat cardiac tissue repair. Int J Biochem Cell Biol 29: 31-42, 1997.
61. Willems IE, Havenith MG, De Mey JG, Daemen MJ. The α-smooth muscle act in-positive cells in healing human myocardial scars. Am J Pathol 145: 868-875, 1994.
62. Yano T, Miura T, Ikeda Y, Matsuda E, Saito K, Miki T, Kobayashi H, Nishino Y, Ohtani S, Shimamoto K. Intra cardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. Cardiovasc Pathol 14: 241-246, 2005.
63. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res 35, Suppl II: 17-26, 1974.
64. Zeisberg EM, Kalluri R. Origins of cardiac fibroblasts. Circ Res 107:1304-1312, 2010.
65. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchy mal transition contributes to cardiac fibrosis. Nat Med 13: 952-961, 2007.
66. Zhang W, Anger T, Su J, Hao J, Xu X, Zhu M, Gach A, Cui L, Liao R, Mende U. Selective loss of fine tuning of Gq/11 signaling by RGS2protein exacerbates cardiomyocyte hypertrophy. J Biol Chem 281: 5811-5820, 2006.
67. Zheng B, De Vries L, Gist Farquhar M. Divergence of RGS proteins: evidence for the existence of six mammalian RGS subfamilies. Trends Biochem Sci 24: 411-414, 1999.
68. Zou MX, Roy AA, Zhao Q, Kirshenbaum LA, Karmazyn M, Chidiac P. RGS2 is up regulated by and attenuates the hypertrophic effect of α1-adrenergic activation in cultured ventricular myocytes. Cell Signal 18:1655-1663, 2006.